Crossmark

Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

Published Online: 2022-06-27

Published Print: 2022-08

Authors

Nuara, Stephen G.

Gourdon, Jim C.

Huot, Philippe https://orcid.org/0000-0002-5464-8334
License Information

Text and Data Mining valid from 2022-06-27

Version of Record valid from 2022-06-27
More Information

Article History

Received: 26 March 2022

Revised: 1 June 2022

Accepted: 5 June 2022

First Online: 27 June 2022

Declarations

:

: There are no conflicts of interest related to the work presented here. PH has received consultancy fees and payments from adMare BioInnovations, Throughline Strategies, Sanford Burnham Prebys, Neurodiem, Sunovion and AbbVie.

Document is current